DDW: 1999 to 2020 Saw Rise in Incidence of Colorectal Cancer in People Under 45
MONDAY, May 13, 2024 (HealthDay News) — For individuals aged younger than 45 years, the...
Read More
Hematology/Oncology
Symptom Burden Prevalent in Childhood Cancer Survivors
THURSDAY, May 9, 2024 (HealthDay News) — Symptom burden is prevalent among young childhood...
Read More
Racial, Ethnic Differences Seen in Breast Cancer Treatment Declination
THURSDAY, May 9, 2024 (HealthDay News) — For patients with breast cancer, there are racial...
Read More
Risk for Colorectal Cancer Is Low for Uncomplicated Diverticulitis
TUESDAY, May 7, 2024 (HealthDay News) — The prevalence of colorectal cancer (CRC) is low for...
Read More
Most Socially Vulnerable Counties Less Likely to Have Cancer Trials
TUESDAY, May 7, 2024 (HealthDay News) — The most socially vulnerable counties are less...
Read More
Hematopoietic Cell Transplantation Use Has Increased for All Racial Groups
MONDAY, May 6, 2024 (HealthDay News) — Hematopoietic cell transplantation (HCT) use has...
Read More
Text Message Outreach Can Help Increase Mammogram Completion Rates
MONDAY, May 6, 2024 (HealthDay News) — Text messaging women after initial outreach for...
Read More
Mortality Risk Up for Cancer Survivors With Elevated Loneliness
MONDAY, May 6, 2024 (HealthDay News) — Cancer survivors with elevated loneliness have a...
Read More
Johnson & Johnson Will Pay $6.5 Billion to Settle Talc Ovarian Cancer Lawsuits
THURSDAY, May 2, 2024 (HealthDay News) — Johnson & Johnson announced Wednesday that it...
Read More
Recombinant ADAMTS13 Effective, Safe in Congenital Thrombotic Thrombocytopenic Purpura
THURSDAY, May 2, 2024 (HealthDay News) — Prophylaxis with recombinant ADAMTS13 in...
Read More
Survival Gains Seen With Assignment to Experimental Group in Cancer Trials
TUESDAY, April 30, 2024 (HealthDay News) — For patients with solid tumors, assignment to an...
Read More
CD7 CAR T-Cell Therapy, Stem-Cell Transplant Beneficial for CD7-Positive Tumors
THURSDAY, April 25, 2024 (HealthDay News) — For patients with relapsed or refractory...
Read More
Exa-Cel Eliminates Vaso-Occlusive Crises in Most Sickle Cell Patients
THURSDAY, April 25, 2024 (HealthDay News) — For almost all patients with sickle cell...
Read More
Seafood Consumption Tied to ‘Forever Chemical’ Exposure Risk
WEDNESDAY, April 24, 2024 (HealthDay News) — Northeastern U.S. seafood consumers may be...
Read More
GLP1 Receptor Agonist Use Does Not Seem to Increase Risk for Thyroid Cancer
WEDNESDAY, April 24, 2024 (HealthDay News) — Glucagon-like peptide 1 (GLP1) receptor agonist...
Read More
Mortality Up for Breast Cancer Diagnosed Five to <10 Years After Childbirth
WEDNESDAY, April 24, 2024 (HealthDay News) — Young-onset breast cancer (YOBC) with germline...
Read More
Few Cancer Survivors Fully Adherent to ACS Nutrition and Physical Activity Guidelines
TUESDAY, April 23, 2024 (HealthDay News) — Only 4 percent of cancer survivors are fully...
Read More
EPA Designates Two ‘Forever Chemicals’ as Hazardous
MONDAY, April 22, 2024 (HealthDay News) — Two common PFAS “forever chemicals”...
Read More
Aspirin May Enhance Immunosurveillance Against Colorectal Cancer
MONDAY, April 22, 2024 (HealthDay News) — Aspirin may promote an immune response against...
Read More
American Association for Cancer Research, April 5-10
The annual meeting of the American Association for Cancer Research was held this year from April 5...
Read More